angelicin

11/01/2013 - "Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways."
01/01/2020 - "Future research on the drug delivery of angelicin in cancer, inflammation and erythroid differentiation models would aid in improving the bioproperties of angelicin and efficacy of delivery to the targeted site. "
01/01/2021 - "Previous studies have revealed that angelicin has an inhibitory effect on inflammation (Wei et al., 2016; Inflammation, 39, 1876-1882), tumor growth (Li et al., 2016; Oncology reports, 36, 3,504-3,512; Wang et al., 2017; Molecular Medicine Reports, 16, 5441-5449), DNA damage (Li et al., 2019; Exp. Ther. "
03/30/2023 - "Angelicin treatment could not only significantly reduce the Iso-induced embryonic inflammation and BBB disruption but also improve the cognitive dysfunction of offspring mice. "
05/01/2019 - "It is concluded that psoralen could improve the adipogenesis of LO2 cells induced by PA; both psoralen and isopsoralen are effective in ameliorating LO2 cells injury induced by PA,reducing inflammation via inhibiting the activation of NF-κB and down-regulating the expression of TGF-β1."

10/01/2017 - "Previous studies have reported that angelicin exerted antiproliferative effects on several types of tumor cell. "
11/15/2023 - "Angelicin could reduce tumor formation, DUSP6, and c-MYC expression in vivo. "
11/15/2023 - "Angelicin has been reported to have antitumor effects on many types of cancer. "
05/01/2023 - "Finally, we found that angelicin could inhibit the growth of tumor and reduce the expression of YAP in the subcutaneous xenograft model of GBM in nude mice and the syngeneic intracranial orthotopic model of GBM in C57BL/6 mice. "
11/01/2019 - "Angelicin is an active compound isolated from the Chinese herb Angelica archangelica, which has been reported to exert antitumor effects by inhibiting malignant behaviors in several types of tumor, including proliferation, colony formation, migration and invasion. "

04/17/2023 - "A study on the anti-osteoporosis mechanism of isopsoralen based on network pharmacology and molecular experiments."
10/01/2023 - "Our findings demonstrated that isopsoralen induced osteogenic differentiation by inhibiting Notch signaling and it might be a potential therapeutic agent for treating or preventing osteoporosis."
01/01/2018 - "These findings demonstrated that isopsoralen prevented osteoporosis through the regulation of PPAR‑γ/WNT, inhibiting oxidative stress by targeting the PPAR‑γ/WNT pathway. "
01/01/2018 - "Isopsoralen regulates PPAR‑γ/WNT to inhibit oxidative stress in osteoporosis."
03/01/2011 - "Isopsoralen may be the active ingredients of preventing anti-osteoporosis in Psoralea corylifolia."

01/01/2018 - "The in vivo study also indicated the effect of angelicin regarding protection against periodontitis. "
01/01/2020 - "Apart from that, recently, a new application for angelicin against periodontitis had been studied, where reduction of bone loss was indirectly caused by its anti-microbial properties. "
01/01/2018 - "Finally, the effects of angelicin on a mouse model of periodontitis were also investigated. "
01/01/2020 - "More in-depth studies of angelicin on bone remodeling, the pro-osteogenic effect of angelicin in various bone disease models and the anti-viral implications of angelicin in periodontitis should be researched. "
01/01/2018 - "Our study highlighted the potential ability of psoralen and angelicin to act as novel natural agents to prevent and treat periodontitis."

12/01/2016 - "The purpose of this study was to determine the protective effects of angelicin on allergic asthma induced by ovalbumin (OVA) in mice. "
12/01/2016 - "Effects of Angelicin on Ovalbumin (OVA)-Induced Airway Inflammation in a Mouse Model of Asthma."